1. Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay

   • Huan Chen
   • Da Tran
   • Yumei Ye

   Original Article 25 April 2020 Pages: 443 - 461

   

2. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway

   • Xing Chen
   • Xingzuan Jiang
   • Shiming Liu

   Routine Article 11 May 2020 Pages: 463 - 473

   

3. Single-Strand DNA-Like Oligonucleotide Aptamer Against Proprotein Convertase Subtilisin/Kexin 9 Using CE-SELEX: PCSK9 Targeting Selection

   • Roohollah Sattari
   • Abbasali Palizban
   • Hossein Khanahmad

   Original Article 15 May 2020 Pages: 475 - 485

   

4. Titin and CK2α are New Intracellular Targets in Acute Insulin Application-Associated Benefits on Electrophysiological Parameters of Left Ventricular Cardiomyocytes From Insulin-Resistant Metabolic Syndrome Rats

   • Aysegul Durak
   • Ceylan V. Bitirim
   • Belma Turan

   Original Article 06 May 2020 Pages: 487 - 501

   

5. Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection Fraction

   • Yajun Gui
   • Jingyuan Chen
   • Danyan Xu

   Review Article 11 May 2020 Pages: 503 - 513

   

6. Regional Variations in Alirocumab Dosing Patterns in Patients with Heterozygous Familial Hypercholesterolemia During an Open-Label Extension Study

   • Gisle Langslet
   • G. Kees Hovingh
   • Michel Farnier

   Original Article Open access 04 May 2020 Pages: 515 - 523

   

7. Effects of Xuezhitong in Patients with Hypertriglyceridemia: a Multicentre, Randomized, Double-Blind, Double Simulation, Positive Drug and Placebo Parallel Control Study

   • Wenhao Jia
   • Yan Li
   • Qian Lin

   Original Article Open access 23 March 2020 Pages: 525 - 534

   

8. Artificial Intelligence Uncovered Clinical Factors for Cardiovascular Events in Myocardial Infarction Patients with Glucose Intolerance

   • Kazuhiro Shindo
   • Hiroki Fukuda
   • Masafumi Kitakaze

   Original Article 12 May 2020 Pages: 535 - 545

   

9. Inpatient Initiation of Oral Treprostinil in an Academic Medical System

   • Benjamin Hohlfelder
   • Adriano R. Tonelli
   • Seth R. Bauer

   Original Article 19 May 2020 Pages: 547 - 553

   

10. Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

    • Andreas Schäfer
    • Ulrike Flierl
    • Johann Bauersachs

    Review Article Open access 29 April 2020 Pages: 555 - 568

    

11. Non-Vitamin K Antagonist Oral Anticoagulants in Secondary Stroke Prevention in Atrial Fibrillation Patients: An Updated Analysis by Adding Observational Studies

    • Xin Liu
    • Zi-Xuan Xu
    • Wen-Gen Zhu

    Review Article 15 April 2020 Pages: 569 - 578

    

12. Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare

    • Michael Gillette
    • Addison Taylor
    • Hani Jneid

    Editorial 21 April 2020 Pages: 579 - 584

13. A Call for Vaccine Against COVID-19: Implications for Cardiovascular Morbidity and Healthcare Utilization

    • Jamie S. Y. Ho
    • Paul A. Tambyah
    • Ching-Hui Sia

    Letter to the Editor 08 May 2020 Pages: 585 - 587

14. Letter to the Editor: Increased Circulating Angiopoietin-like Protein 8 Levels Are Associated with Thoracic Aortic Dissection and Higher Inflammatory Conditions

    • Xiaoming Jia

    Letter to the Editor 04 May 2020 Pages: 589 - 589